Govindan, R., Fakih, M. G., Price, T. J., Falchook, G. S., Desai, J., Kuo, J. C., … Hong, D. S. (2019). Phase I study of AMG 510, a novel molecule targeting KRAS G12C mutant solid tumours. In ANNALS OF ONCOLOGY (Vol. 30, pp. 163-+). Barcelona, SPAIN: OXFORD UNIV PRESS.

Govindan, R., M. G. Fakih, T. J. Price, G. S. Falchook, J. Desai, J. C. Kuo, J. H. Strickler, et al. “Phase I study of AMG 510, a novel molecule targeting KRAS G12C mutant solid tumours.” In ANNALS OF ONCOLOGY, 30:163-+. OXFORD UNIV PRESS, 2019.

Govindan R, Fakih MG, Price TJ, Falchook GS, Desai J, Kuo JC, et al. Phase I study of AMG 510, a novel molecule targeting KRAS G12C mutant solid tumours. In: ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2019. p. 163-+.

Govindan, R., et al. “Phase I study of AMG 510, a novel molecule targeting KRAS G12C mutant solid tumours.” ANNALS OF ONCOLOGY, vol. 30, OXFORD UNIV PRESS, 2019, pp. 163-+.

Govindan R, Fakih MG, Price TJ, Falchook GS, Desai J, Kuo JC, Strickler JH, Krauss JC, Li BT, Denlinger CS, Durm G, Ngang J, Henary H, Ngarmchamnanrith G, Rasmussen E, Morrow PK, Hong DS. Phase I study of AMG 510, a novel molecule targeting KRAS G12C mutant solid tumours. ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2019. p. 163-+.